PHARMADOX HEALTHCARE LIMITED — Rivaroxaban Importer Profile
Pharmaceutical Importer · #5 buyer for Rivaroxaban · $894.8K import value · 50 shipments · MALTA · DGFT Verified
PHARMADOX HEALTHCARE LIMITED is the #5 importer of Rivaroxaban from India with $894.8K in import value and 50 verified shipments. PHARMADOX HEALTHCARE LIMITED holds a 7.5% market share in Rivaroxaban imports based in MALTA. The company sources from 4 verified suppliers across 39 formulations shipped to 1 country. Overall, PHARMADOX HEALTHCARE LIMITED imports 6 pharmaceutical products worth $7.6M across 4 therapeutic categories.
PHARMADOX HEALTHCARE LIMITED — Rivaroxaban Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Rivaroxaban to PHARMADOX HEALTHCARE LIMITED?
Verified from 50 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ZENTIVA PRIVATE LIMITED | $726.1K | 35 | 81.1% |
| UNISON PHARMACEUTICALS PRIVATE LIMITED | $168.6K | 6 | 18.8% |
| INTAS PHARMACEUTICALS LIMITED | $61 | 1 | 0.0% |
| DR REDDY S LABORATORIES LIMITED | $49 | 8 | 0.0% |
PHARMADOX HEALTHCARE LIMITED sources Rivaroxaban from 4 verified Indian suppliers based on 50 customs records. The primary supplier is ZENTIVA PRIVATE LIMITED accounting for 81.1% of imports.
How Does PHARMADOX HEALTHCARE LIMITED Compare to Nearest Rivaroxaban Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | PHARMADOX HEALTHCARE LTD | MALTA | $3.9M | 194 | $20.3K |
| 4 | APOTEX INC | CANADA | $1.3M | 27 | $46.9K |
| 5 | PHARMADOX HEALTHCARE LIMITED ★ | MALTA | $1.1M | 50 | $21.0K |
| 7 | MYLAN IRELAND C/O ALLOGA RDC,. | NETHERLANDS | $911.1K | 46 | $19.8K |
| 9 | BIOLAB FARMA GENERICO | BRAZIL | $750.0K | 15 | $50.0K |
PHARMADOX HEALTHCARE LIMITED ranks #5 among 497 Rivaroxaban importers from India. Average shipment value of $21.0K compared to the market average of $33.2K. The closest competitors by value are PHARMADOX HEALTHCARE LTD and APOTEX INC.
Where Does PHARMADOX HEALTHCARE LIMITED Import Rivaroxaban To?
Destination countries from 50 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALTA | $894.8K | 50 | 100.0% |
PHARMADOX HEALTHCARE LIMITED imports Rivaroxaban to 1 country. The primary destination is MALTA receiving 100.0% of shipments worth $894.8K.
What Rivaroxaban Formulations Does PHARMADOX HEALTHCARE LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS - RIVAROXABAN ZTV 20MG TABCO BL2X14 M24 FR (51772 PCS)PCS | $152.7K | 6 |
| PHARAMACEUTICAL PRODUCTS RIVAROXABAN 20MG TABCO BL7X14 M24 DE ZMID CODE: 938898PCS | $141.4K | 3 |
| PHARAMACEUTICAL PRODUCTS RIVAROXABAN ZTV 20MG TABCO BL2X14 M24 PT ZMID CODE: 938087PCS | $73.3K | 3 |
| PHARMACEUTICAL PRODUCTS - RIVAROXABAN 20MG TABCO BL7X14 M24 DE (19935PCS)PCS | $50.0K | 1 |
| RIVAROXABAN 20 MG FC TABLETS(2X14T)BL (RIVAROXABAN) (2X14)(1NOS=1PACKS) B.NO. 2331055 AS PER INV | $50.0K | 1 |
| RIVAROXABAN 20 MG FC TABLETS(2X14T)BL (RIVAROXABAN)(2X14)(1NOS=1PACKS) B.NO. 2430051,52 AS PER INV | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS - RIVAROXABAN 20MG TABCO BL7X14 M24 DE (4933 PCS)PCS | $48.7K | 2 |
| PHARMACEUTICAL PRODUCTS - RIVAROXABAN ZTV 20MG TABCO BL2X14 M24 PT (17364 PCS)PCS | $48.3K | 2 |
| PHARAMACEUTICAL PRODUCTS RIVAROXABAN 10MG TABCO BL7X14 M36 DE ZMID CODE: 938910PCS | $37.9K | 1 |
| RIVAROXABAN 20MG TABCO BL2X14 M24 GB ZMID CODE: 938938PHARAMACEUTICAL PRODUCTS | $35.9K | 1 |
PHARMADOX HEALTHCARE LIMITED imports 39 distinct Rivaroxaban formulations from India. The top formulation is PHARMACEUTICAL PRODUCTS - RIVAROXABAN ZTV 20MG TABCO BL2X14 with 6 shipments worth $152.7K.
Who Are the Top Buyers of Rivaroxaban from India and How Much Does PHARMADOX HEALTHCARE LIMITED Import?
India exported $16.5M worth of Rivaroxaban through 5,361 shipments from 221 suppliers to 115 countries, serving 497 buyers globally. PHARMADOX HEALTHCARE LIMITED imports $894.8K of this total, accounting for 7.5% of India's Rivaroxaban exports with 50 shipments from MALTA. This is verified from 50 customs shipment records covering 39 distinct formulations.
What Is the Average Order Value for PHARMADOX HEALTHCARE LIMITED's Rivaroxaban Imports?
PHARMADOX HEALTHCARE LIMITED's average Rivaroxaban order value is $17.9K per consignment, based on 50 shipments totaling $894.8K. PHARMADOX HEALTHCARE LIMITED is based in MALTA and ranks #5 among all Rivaroxaban importers from India by value. The company sources from 4 verified suppliers in India.
Who Supplies Rivaroxaban to PHARMADOX HEALTHCARE LIMITED?
PHARMADOX HEALTHCARE LIMITED sources Rivaroxaban from 4 verified Indian suppliers: ZENTIVA PRIVATE LIMITED ($726.1K, 81.1%), UNISON PHARMACEUTICALS PRIVATE LIMITED ($168.6K, 18.8%), INTAS PHARMACEUTICALS LIMITED ($61, 0.0%), DR REDDY S LABORATORIES LIMITED ($49, 0.0%). This is based on 50 customs records.
How Does PHARMADOX HEALTHCARE LIMITED Compare to Other Rivaroxaban Importers?
PHARMADOX HEALTHCARE LIMITED ranks #5 among 497 Rivaroxaban importers from India with a 7.5% market share. The top 3 importers are MYLAN IRELAND C/O ALLOGA RDC, ($4.2M), PHARMADOX HEALTHCARE LTD ($3.9M), APOTEX INC ($1.3M). PHARMADOX HEALTHCARE LIMITED processed 50 shipments from MALTA.
What Other Cardiovascular Products Does PHARMADOX HEALTHCARE LIMITED Import?
PHARMADOX HEALTHCARE LIMITED also imports these cardiovascular products. Each links to the detailed product page.
About PHARMADOX HEALTHCARE LIMITED
PHARMADOX HEALTHCARE LIMITED imports 6 products worth $7.6M. Beyond Rivaroxaban, top products include Apixaban, Cabazitaxel, Acetylsalicylic, Salicylic, Vati. View the complete PHARMADOX HEALTHCARE LIMITED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rivaroxaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PHARMADOX HEALTHCARE LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PHARMADOX HEALTHCARE LIMITED's capped import value divided by total capped export value for Rivaroxaban across all Indian exporters.
- 5.Verified Records: This page is backed by 50 individual customs records matching PHARMADOX HEALTHCARE LIMITED importing Rivaroxaban, covering 39 formulations from 4 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 497+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rivaroxaban Import Data for PHARMADOX HEALTHCARE LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for PHARMADOX HEALTHCARE LIMITED's Rivaroxaban imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PHARMADOX HEALTHCARE LIMITED
Full Company Profile →
6 products · $7.6M total trade · 4 categories
PHARMADOX HEALTHCARE LIMITED × Rivaroxaban
Verified from customs records
Company Overview
Top Products by PHARMADOX HEALTHCARE LIMITED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PHARMADOX HEALTHCARE LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rivaroxaban. For current order-level data, contact TransData Nexus.